CannRx Technology Inc. is a US-based corporation and a subsidiary of Izun Pharmaceuticals Corporation. CannRx was established to become a leader in the development of medical applications for the cannabis plant.  CannRx differentiates itself from the complicated legal and social issues being debated on an almost daily basis with respect to cannabis usage. Instead it is the primary intent of CannRx to leverage off an established, patented technology platform that has been developed and apply it to the cannabis plant and establish itself as a market leader in the development of medical applications.